Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.650
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
2.640
-0.010 (-0.38%)
After-hours: May 12, 2025, 4:35 PM EDT
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 70 employees as of December 31, 2024. The number of employees increased by 14 or 25.00% compared to the previous year.
Employees
70
Change (1Y)
14
Growth (1Y)
25.00%
Revenue / Employee
$37,686
Profits / Employee
-$871,771
Market Cap
101.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OBIO News
- 7 hours ago - Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones - GlobeNewsWire
- 5 days ago - Orchestra BioMed's AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure - GlobeNewsWire
- 13 days ago - Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon - GlobeNewsWire
- 14 days ago - Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewsWire
- 19 days ago - Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting - GlobeNewsWire
- 20 days ago - Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy - GlobeNewsWire
- 6 weeks ago - Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update - GlobeNewsWire
- 2 months ago - Orchestra BioMed to Present at Upcoming Investor Conferences - GlobeNewsWire